These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 23541012)

  • 1. My approach to the treatment of scleroderma.
    Shah AA; Wigley FM
    Mayo Clin Proc; 2013 Apr; 88(4):377-93. PubMed ID: 23541012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic sclerosis/scleroderma: a treatable multisystem disease.
    Hinchcliff M; Varga J
    Am Fam Physician; 2008 Oct; 78(8):961-8. PubMed ID: 18953973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scleroderma in Children and Adolescents: Localized Scleroderma and Systemic Sclerosis.
    Li SC
    Pediatr Clin North Am; 2018 Aug; 65(4):757-781. PubMed ID: 30031497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Treatment Options in Scleroderma: Recommendations and Comprehensive Review.
    Zhao M; Wu J; Wu H; Sawalha AH; Lu Q
    Clin Rev Allergy Immunol; 2022 Apr; 62(2):273-291. PubMed ID: 33449302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN).
    Thombs BD; Jewett LR; Assassi S; Baron M; Bartlett SJ; Maia AC; El-Baalbaki G; Furst DE; Gottesman K; Haythornthwaite JA; Hudson M; Impens A; Korner A; Leite C; Mayes MD; Malcarne VL; Motivala SJ; Mouthon L; Nielson WR; Plante D; Poiraudeau S; Poole JL; Pope J; Sauve M; Steele RJ; Suarez-Almazor ME; Taillefer S; van den Ende CH; Arthurs E; Bassel M; Delisle V; Milette K; Leavens A; Razykov I; Khanna D
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S23-9. PubMed ID: 22244687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope.
    Saketkoo LA; Magnus JH; Doyle MK
    Am J Med Sci; 2014 Jan; 347(1):54-63. PubMed ID: 24366221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical manifestations of systemic sclerosis.
    Steen VD
    Semin Cutan Med Surg; 1998 Mar; 17(1):48-54. PubMed ID: 9512107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
    Steen VD; Medsger TA
    Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics and Factors Associated With Disability and Impaired Quality of Life in Children With Juvenile Systemic Sclerosis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.
    Stevens BE; Torok KS; Li SC; Hershey N; Curran M; Higgins GC; Moore KF; Egla Rabinovich C; Dodson S; Stevens AM;
    Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1806-1813. PubMed ID: 29457372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Juvenile scleroderma].
    de Mâcedo PA; Shinjo SK; Goldenstein-Schainberg C
    Acta Reumatol Port; 2008; 33(3):289-97. PubMed ID: 18846006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic sclerosis.
    Denton CP; Khanna D
    Lancet; 2017 Oct; 390(10103):1685-1699. PubMed ID: 28413064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune Skin Conditions: Systemic Sclerosis.
    Helm LA; Clebak KT; Foulke G; Helm M
    FP Essent; 2023 Mar; 526():18-24. PubMed ID: 36913659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Scleroderma].
    Distler O; Gay S
    Internist (Berl); 2010 Jan; 51(1):30-8. PubMed ID: 20033389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile Scleroderma-What has Changed in the Meantime?
    Adrovic A; Sahin S; Barut K; Kasapcopur O
    Curr Rheumatol Rev; 2018; 14(3):219-225. PubMed ID: 29692255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and strategies for coping with scleroderma: implications for a scleroderma-specific self-management program.
    Milette K; Thombs BD; Maiorino K; Nielson WR; Körner A; Peláez S
    Disabil Rehabil; 2019 Oct; 41(21):2506-2515. PubMed ID: 29741963
    [No Abstract]   [Full Text] [Related]  

  • 16. [Systemic sclerosis--clinical course and treatment possibilities].
    Szymańska E; Maj M; Rudnicka L
    Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An update on systemic sclerosis].
    Kowal-Bielecka O
    Ann Acad Med Stetin; 2010; 56 Suppl 1():80-2. PubMed ID: 21365948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic sclerosis.
    Volkmann ER; Andréasson K; Smith V
    Lancet; 2023 Jan; 401(10373):304-318. PubMed ID: 36442487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the diagnosis and treatment of interstitial lung disease in systemic sclerosis (scleroderma): a review.
    Tan A; Denton CP; Mikhailidis DP; Seifalian AM
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S66-74. PubMed ID: 21586221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous manifestations of selected rheumatologic diseases.
    Ostezan LB; Callen JP
    Am Fam Physician; 1996 Apr; 53(5):1625-36. PubMed ID: 8623690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.